Clinical Trials at Urology of VirginiaOur staff’s experienced investigators and certified clinical research coordinators closely monitor participating patients during the course of a study period. All clinical trials are conducted according to the principles of Good Clinical Practice (GCPs) as mandated by the FDA.
For questions and information about our clinical trials, please contact us at research@urologyofva.net
No current meeting notes.
- Participants have access to advanced medications or devices before they become available to the public.
- Clinical study procedures may be provided to you at no cost.
- Participants often express enthusiasm for contributing to medical science.
- Today’s clinical research can positively impact future generations.
Enrolling Clinical Studies at Urology of Virginia
CG Oncology CORE-008: A Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer.
Get detailed information about this clinical trial»
CG Oncology PIVOT-006: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
Phase 3, open-label, randomized trial designed to evaluate the recurrence free survival of TURBT followed by cretostimogene grenadenorepvec versus TURBT followed by observation for the treatment of participants with intermediate risk non-muscle invasive bladder cancer.
Get detailed information about this clinical trial»
Ferring ABLE-32: Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Study designed to evaluate the efficacy of nadofaragene firadenovac vs. observation in subjects with non-muscle invasive bladder cancer.
Get detailed information about this clinical trial»
Ferring ABLE-41: ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States
Multi-center, prospective non-interventional study to collect data on the early use of ADSTILADRIN in the US. Data will be collected from participants, caregivers and prescribing physicians in a real-world setting.
Get detailed information about this clinical trial»
ImmunityBio QUILT-2.005: A Study of Intravesical BCG in Combination With ALT-803 in BCG Naïve Patients with High-Grade, Non-Muscle Invasive Bladder Cancer
This is a Phase Ib/IIb, randomized, two-cohort, open-label, multicenter study of intravesical N-803 plus BCG versus BCG alone, in BCG naïve patients with high-grade NMIBC.
Get detailed information about this clinical trial»
Merck Sharp & Dohme: A Phase 2 Open-label Randomized Study of V940 in Combination With BCG Versus BCG Monotherapy in Participants With High-risk Non-muscle Invasive Bladder Cancer (INTerpath-011)
The purpose of this study is to learn if adding V940, the study treatment, to standard treatment can help treat HR NMIBC.
Expected Management
Canary PASS:
A multicenter, prospective active surveillance study with selective intervention in patients with previously untreated, clinically localized prostate cancer at diagnosis. The objective is to discover and confirm biomarkers that predict aggressive disease.
MDxHealth: GPS for Prostate Cancer Decision Impact Trial (Pro-CDI Trial)
The purpose of this study is to assess the impact of GPS on initial treatment decision-making.
Hormone Therapy (ADT)/ Other Treatments
Debiopharma Debio 4228: A Dose Finding Study of Debio 4228 in Participants with Locally Advanced/Metastatic Prostate Cancer
The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.
Get detailed information about this clinical trial»
Levee Medical ARID II: A Pivotal Study of Voro Urologic Scaffold for the Treatment of Post Prostatectomy Stress Urinary Incontinence
The purpose of this study is to compare safety and effectiveness of the Voro Urologic Scaffold in adult men undergoing robotic assisted radical prostatectomy as compared to control arm.
Get detailed information about this clinical trial»
Metastatic disease: Cancer that has spread to other areas
Debiopharma Debio 4228: A Dose Finding Study of Debio 4228 in Participants with Locally Advanced/Metastatic Prostate Cancer
The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.
Get detailed information about this clinical trial»
Dendreon ProvONE: Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T (ProvONE)
A multicenter, open-label, prospective study to investigate immune boost response changes in patients with metastatic castrate-resistant prostate cancer (mCRPC).
BPH (Enlarged Prostate)
No Enrolling Studies at This Time
Hypogonadism/Low Testosterone
No Enrolling Studies at This Time
Incontinence
No Enrolling Studies at This Time
Interstitial Cystitis
No Enrolling Studies at This Time
Nocturia
No Enrolling Studies at This Time
Pelvic Organ Prolapse
No Enrolling Studies at This Time
Stone Disease
AVVIO ELS: Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial
The purpose of this trial is to demonstrate the safety and efficacy of the Enhanced Lithotripsy System (ELS) in patients with a urinary stone within the ureter (proximal, middle, or distal).
Urethral Stricture
No Enrolling Studies at This Time